141 related articles for article (PubMed ID: 14523533)
21. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.
Gröbe A; Hanken H; Kluwe L; Schöllchen M; Tribius S; Pohlenz P; Clauditz T; Grob T; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2013 Oct; 42(9):676-81. PubMed ID: 23721566
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
[TBL] [Abstract][Full Text] [Related]
24. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
[TBL] [Abstract][Full Text] [Related]
25. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
26. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
27. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
[TBL] [Abstract][Full Text] [Related]
28. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
29. Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma.
Rodrigo JP; Suárez C; Ferlito A; Devaney KO; Petruzzelli GJ; Rinaldo A
Acta Otolaryngol; 2003 Jan; 123(1):100-5. PubMed ID: 12625582
[No Abstract] [Full Text] [Related]
30. Head and neck cancer: the importance of oxygen.
Terris DJ
Laryngoscope; 2000 May; 110(5 Pt 1):697-707. PubMed ID: 10807350
[TBL] [Abstract][Full Text] [Related]
31. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
32. The violated neck: cervical node biopsy prior to definitive treatment.
Robbins KT; Cole R; Marvel J; Fields R; Wolf P; Goepfert H
Otolaryngol Head Neck Surg; 1986 Jun; 94(5):605-10. PubMed ID: 3088524
[TBL] [Abstract][Full Text] [Related]
33. [Effect of various forms of metastatic lymph node involvement on prognosis of squamous epithelial carcinomas of the upper aerodigestive tract].
Kehrl W; Wenzel S; Niendorf A
Laryngorhinootologie; 1998 Oct; 77(10):569-75. PubMed ID: 9842521
[TBL] [Abstract][Full Text] [Related]
34. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck].
Schipper JH; Kelker W
HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression.
Koskinen WJ; Bono P; Leivo I; Vaheri A; Aaltonen LM; Joensuu H
Radiother Oncol; 2005 Nov; 77(2):172-5. PubMed ID: 16229916
[TBL] [Abstract][Full Text] [Related]
36. Current potential and limitations of molecular diagnostic methods in head and neck cancer.
Mahfouz ME; Rodrigo JP; Takes RP; Elsheikh MN; Rinaldo A; Brakenhoff RH; Ferlito A
Eur Arch Otorhinolaryngol; 2010 Jun; 267(6):851-60. PubMed ID: 20037788
[TBL] [Abstract][Full Text] [Related]
37. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
[TBL] [Abstract][Full Text] [Related]
38. [The sentinel node concept in head and neck squamous cell carcinoma--a critical analysis in 100 patients].
Werner JA; Dünne AA; Ramaswamy A; Brandt D; Külkens C; Folz BJ; Moll R; Lippert BM
Laryngorhinootologie; 2002 Jan; 81(1):31-9. PubMed ID: 11845400
[TBL] [Abstract][Full Text] [Related]
39. [Expression and localization profile of tenascin in squamous cell carcinomas of the head and neck].
Herold-Mende C; Andl T; Laemmler F; Reisser C; Eichhorn S
HNO; 1999 Aug; 47(8):723-9. PubMed ID: 10506500
[TBL] [Abstract][Full Text] [Related]
40. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
